Evidence map›Paper›PMID 31570505›Full record

ArticleJournal of lipid research2019

The three members of the Vav family proteins form complexes that concur to foam cell formation and atherosclerosis.

Rong Huang, Guo Guo, Liaoxun Lu, Rui Fu, Jing Luo, Zhuangzhuang Liu, Yanrong Gu, Wenyi Yang, Qianqian Zheng, Tianzhu Chao and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Xcr1eLife · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. sgRNA Knock-in Mouse Provides an Alternative Approach forFrontiers in cell and developmental biology · 2021
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 3 countries.

Rong HuangLaboratory of Genetic Regulators in the Immune System, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, Henan Province, China.ORCID 0000-0001-6256-7481
Guo GuoLaboratory of Genetic Regulators in the Immune System, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, Henan Province, China.
Liaoxun LuLaboratory of Genetic Regulators in the Immune System, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, Henan Province, China.ORCID 0000-0002-5342-2720
Rui FuLaboratory of Genetic Regulators in the Immune System, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, Henan Province, China.
Jing LuoLaboratory of Genetic Regulators in the Immune System, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, Henan Province, China.
Zhuangzhuang LiuInstitute of Psychiatry and Neuroscience, Xinxiang Medical University, Henan Province, China.ORCID 0000-0001-5621-038X
Yanrong GuLaboratory of Genetic Regulators in the Immune System, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, Henan Province, China.
Wenyi YangLaboratory of Genetic Regulators in the Immune System, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, Henan Province, China.
Qianqian ZhengLaboratory of Genetic Regulators in the Immune System, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, Henan Province, China.
Tianzhu ChaoInstitute of Psychiatry and Neuroscience, Xinxiang Medical University, Henan Province, China.
Le HeHenan Key Laboratory of Immunology and Targeted Therapy, School of Laboratory Medicine, Xinxiang Medical University, Henan Province, China.
Ying WangInstitute of Psychiatry and Neuroscience, Xinxiang Medical University, Henan Province, China.
Zhiguo NiuHenan Key Laboratory of Immunology and Targeted Therapy, School of Laboratory Medicine, Xinxiang Medical University, Henan Province, China.
Hui WangHenan Key Laboratory of Immunology and Targeted Therapy, School of Laboratory Medicine, Xinxiang Medical University, Henan Province, China.
Toby LawrenceCentre for Inflammation Biology and Cancer Immunology, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.ORCID 0000-0003-0967-6122
Marie MalissenCentre d'Immunologie de Marseille-Luminy, UM2 Aix-Marseille Université, Marseille, France.ORCID 0000-0003-2331-1445
Bernard MalissenCentre d'Immunologie de Marseille-Luminy, UM2 Aix-Marseille Université, Marseille, France.ORCID 0000-0003-1340-9342
Yinming LiangLaboratory of Genetic Regulators in the Immune System, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, Henan Province, China yinming.liang@foxmail.com zhanglichen@xxmu.edu.cn.ORCID 0000-0001-9174-4037
Lichen ZhangLaboratory of Genetic Regulators in the Immune System, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, Henan Province, China yinming.liang@foxmail.com zhanglichen@xxmu.edu.cn.ORCID 0000-0002-7810-9941
Xinxiang Medical University · CNCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During foam cell formation and atherosclerosis development, the scavenger receptor CD36 plays critical roles in lipid uptake and triggering of atherogenicity via the activation of Vav molecules. The Vav family includes three highly conserved members known as Vav1, Vav2, and Vav3. As Vav1 and Vav3 were found to exert function in atherosclerosis development, it remains thus to decipher whether Vav2 also plays a role in the development of atherosclerosis. In this study we found that Vav2 deficiency in RAW264.7 macrophages significantly diminished oxidized LDL uptake and CD36 signaling, demonstrating that each Vav protein family member was required for foam cell formation. Genetic disruption of Vav2 in ApoE-deficient C57BL/6 mice significantly inhibited the severity of atherosclerosis. Strikingly, we further found that the genetic deletion of each member of the Vav protein family by CRISPR/Cas9 resulted in a similar alteration of transcriptomic profiles of macrophages. The three members of the Vav proteins were found to form complexes, and genetic ablation of each single Vav molecule was sufficient to prevent endocytosis of CD36. The functional interdependence of the three Vav family members in foam cell formation was due to their indispensable roles in transcriptomic programing, lipid uptake, and activation of the JNK kinase in macrophages.

Indexed as

Protein MultimerizationAnimalsApolipoproteins EAtherosclerosisBase SequenceCD36 AntigensCell DifferentiationFoam CellsGene Knockout TechniquesMiceMice, Inbred C57BLPhenotypeProtein Structure, QuaternaryProtein TransportProto-Oncogene Proteins c-vavRAW 264.7 CellsApolipoproteins ECD36 AntigensProto-Oncogene Proteins c-vavCD36endocytosislow-density lipoproteinmetabolismVav2

Identifiers

PMID31570505
PMCPMC6889716
OpenAlexW2978641306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.